(Q86057048)

English

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study

scientific article published on 26 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Marja-Riitta Taskinen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Andrzej S Januszewski

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Rachel O'Connell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Aimin Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

David R Sullivan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Philip J Barter

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Wei-Ting Hung

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Russell S Scott

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Anthony C Keech

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Kerry-Anne Rye

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

26 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

58

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

464-473

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425220%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

https://scigraph.springernature.com/pub.10.1007/s00125-014-3458-7

0 references

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol Metabolism Altered and FGF21 Levels High After Pediatric Liver Transplantation Despite Normal Serum Lipids

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do novel biomarkers add to existing scores of total cardiovascular risk?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FGF21 increases cholesterol efflux by upregulating ABCA1 through the ERK1/2-PPARγ-LXRα pathway in THP1 macrophage-derived foam cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast growth factor 21 mediates specific glucagon actions

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast growth factor 21 protects against cardiac hypertrophy in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FGF-21 as a novel metabolic regulator

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86057048&oldid=1442552230"